Nancy Miller-Rich's Net Worth
$578 Thousand
Who is Nancy Miller-Rich?
Nancy Miller-Rich does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include INTERCEPT PHARMACEUTICALS, INC., Aldeyra Therapeutics, Inc., 4D Molecular Therapeutics, Inc., and Kadmon Holdings, Inc..
SEC CIK
Nancy Miller-Rich's CIK is 0001735084
Past Insider Trading and Trends
2021 was Nancy Miller-Rich's most active year for acquiring shares with 6 total transactions. Nancy Miller-Rich's most active month to acquire stocks was the month of April. 2023 was Nancy Miller-Rich's most active year for disposing of shares, totalling 8 transactions. Nancy Miller-Rich's most active month to dispose stocks was the month of October. 2020 saw Nancy Miller-Rich paying a total of $151,637.88 for 91,692 shares, this is the most they've acquired in one year. In 2021 Nancy Miller-Rich cashed out on 133,339 shares for a total of $767,912.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INTERCEPT PHARMACEUTICALS, INC. (ICPT) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -30.41K |
$19.00 | -$577,885.00 |
0
|
Nov 8
| |||
Form 4
| +36.37% | 8.11K |
—
|
—
| 30.41K |
May 24
| |||
Form 4
| +53.11% | 7.74K |
—
|
—
| 22.3K |
May 25
| |||
Form 4
| +93.25% | 7.03K |
—
|
—
| 14.57K |
May 27
| |||
Form 4
| +26.84% | 1.59K |
—
|
—
| 7.54K |
May 28
| |||
Form 4
| +35.90% | 1.57K |
—
|
—
| 5.94K |
Jun 20
| |||
Form 4
|
∞
| 4.37K |
—
|
—
| 4.37K |
Jun 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aldeyra Therapeutics, Inc. (ALDX) Snapshot price: $6.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 922 |
$11.33 | $10,446.70 | 922 |
May 3 - Apr 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
4D Molecular Therapeutics, Inc. (FDMT) Snapshot price: $15.07
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Kadmon Holdings, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |